fbpx Back to Top

Glioblastoma Multiforme

Get Help with Your Treatment

Apply Online or call 1-866-316-7263


Program Status

Currently Closed – We are no longer accepting or processing applications for new or renewal patients.


For current information, log in to FundFinder.

Assistance Amount

$3,300 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for glioblastoma multiforme.
  2. The patient must have health insurance that covers his or her qualifying medication or product.   
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Bicnu (carmustine)
  • Camptosar (irinotecan hcl)
  • Carboplatin (carboplatin)
  • Carmustine (carmustine)
  • Cisplatin (cisplatin)
  • Cyclophosphamide (cyclophosphamide)
  • Etoposide (etoposide)
  • Gleostine (lomustine)
  • Gliadel (carmustine in polifeprosan 20)
  • Irinotecan Hcl (irinotecan hcl)
  • Marqibo (vincristine sulfate liposomal)
  • Matulane (procarbazine hcl)
  • Mvasi (bevacizumab-awwb)
  • Onivyde (irinotecan liposomal)
  • Paraplatin (carboplatin)
  • Rozlytrek (entrectinib)
  • Temodar (temozolomide)
  • Temozolomide (temozolomide)
  • Toposar (etoposide)
  • Vincasar Pfs (vincristine sulfate)
  • Vincristine Sulfate (vincristine sulfate)
  • Vitrakvi (larotrectinib sulfate)
  • Zirabev (bevacizumab-bvzr)

Diagnosis Codes:

ICD-10: C71.0, C71.1, C71.2, C71.3, C71.4, C71.5, C71.6, C71.7, C71.8, C71.9, C72.9


About the Disease:

Glioblastoma multiforme (GBM), also known as glioblastoma, is a malignant tumor affecting the brain or spine. GBM is a rare disease that affects the nervous system.


Source: National Institutes of Health